Pharmacological studies of Cinnamomum zeylanicum (bark)

Zusatztext

Cinnamomum zeylanicum, native species of Sri Lanka and southern parts of India. Three major components were reported i.e. trans-cinnamaldehyde, eugenol and linalool, which represent 82.5% of the total composition. As per the literature, this species showed various immunobiological activities i.e. lowering of blood glucose, anti-oxidant and free-radical scavenging activity; anti-inflammatory properties along with hepatoprotective effects. In addition, this species reported as less toxic effect but showing considerable economic importance as well e.g. bark used as a spice, perfumery and also used in ayurvedic and traditional Chinese medicine for its hypoglycemic and antiseptic properties. As per the literature, bark of this species is used especially for treating bronchitis, asthma, nausea, vomiting, fever and for restoring normal skin, etc. This study is to evaluate the effect of Cinnamomum zeylanicum using different solvent system and then determined its metabolites qualitatively and also extracted oil from bark of the medicinal plant and analyzing its antimicrobial along with antioxidant property.

Autorenportrait

Dr. Amit Gupta ist Immunologe und arbeitet als außerordentlicher Professor in der Abteilung für Biotechnologie, Graphic Era (Anerkannte Universität, NAAC A-akkreditiert), Indien. Sein Fachgebiet sind präklinische und klinische Studien, d.h. Studien auf Proteasebasis, entzündungshemmende, antimikrobielle Aktivität und Immunmodulation (Impfstoffadjuvantien).

Weitere Details